Literature DB >> 2175209

Relative platelet-derived growth factor receptor subunit expression determines cell migration to different dimeric forms of PDGF.

G A Ferns1, K H Sprugel, R A Seifert, D F Bowen-Pope, J D Kelly, M Murray, E W Raines, R Ross.   

Abstract

Platelet-derived growth factor (PDGF) receptor transfectants of a fibroblastoid cell line (BHK) have been used to investigate the ability of the three dimeric forms of PDGF to elicit a chemotactic response. Cells transfected with the beta receptor subunit were only responsive to PDGF-BB, whereas cells expressing the alpha-receptor subunit were equally responsive to all three dimeric forms, PDGF-AA, PDGF-AB, and PDGF-BB. A positive chemotactic response correlated with rearrangement of actin organization. In a study of human arterial smooth muscle cells that express both PDGF receptor subunits endogenously, we again found that recombinant PDGF-AA could elicit a chemotactic response. However, the two smooth muscle cell isolates we examined differed in their chemotactic response to PDGF-AA. This difference correlated closely with their ability to respond mitogenically to this PDGF dimeric form, and the magnitude of both chemotactic and mitogenic responses was related to the proportion of the two receptor subunit species at the cell surface.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2175209     DOI: 10.3109/08977199009003674

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  21 in total

1.  ERK activation of p21 activated kinase-1 (Pak1) is critical for medulloblastoma cell migration.

Authors:  Liangping Yuan; Mariarita Santi; Elisabeth J Rushing; Robert Cornelison; Tobey J MacDonald
Journal:  Clin Exp Metastasis       Date:  2010-06-06       Impact factor: 5.150

2.  A novel physiological function for platelet-derived growth factor-BB in rat dermis.

Authors:  S A Rodt; K Ahlén; A Berg; K Rubin; R K Reed
Journal:  J Physiol       Date:  1996-08-15       Impact factor: 5.182

3.  G-protein-coupled receptor kinase interacting protein-1 mediates intima formation by regulating vascular smooth muscle proliferation, apoptosis, and migration.

Authors:  Jinjiang Pang; Xiangbin Xu; Xiaoqun Wang; Syamantak Majumder; Jing Wang; Vyacheslav A Korshunov; Bradford C Berk
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02-21       Impact factor: 8.311

Review 4.  Mechanisms of angiotensin II-induced platelet-derived growth factor gene expression.

Authors:  L M Khachigian; Y Takuwa; T Collins
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

5.  RhoE function is regulated by ROCK I-mediated phosphorylation.

Authors:  Kirsi Riento; Nick Totty; Priam Villalonga; Ritu Garg; Rosa Guasch; Anne J Ridley
Journal:  EMBO J       Date:  2005-03-03       Impact factor: 11.598

6.  Urokinase-induced signaling in human vascular smooth muscle cells is mediated by PDGFR-beta.

Authors:  Julia Kiyan; Roman Kiyan; Hermann Haller; Inna Dumler
Journal:  EMBO J       Date:  2005-05-05       Impact factor: 11.598

7.  Periadventitial delivery of anti-EGF receptor antibody inhibits neointimal macrophage accumulation after angioplasty in a hypercholesterolaemic rabbit.

Authors:  Shahida Shafi; David Lamb; Helmout Modjtahedi; Gordon Ferns
Journal:  Int J Exp Pathol       Date:  2009-12-11       Impact factor: 1.925

8.  Balloon catheter de-endothelialization of the nude rat carotid. Response to injury in the absence of functional T lymphocytes.

Authors:  G A Ferns; M A Reidy; R Ross
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

9.  Microvascular pericytes express platelet-derived growth factor-beta receptors in human healing wounds and colorectal adenocarcinoma.

Authors:  C Sundberg; M Ljungström; G Lindmark; B Gerdin; K Rubin
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

10.  Expression of platelet-derived growth factor receptors in normal and diseased human kidney. An immunohistochemistry and in situ hybridization study.

Authors:  L Gesualdo; S Di Paolo; S Milani; M Pinzani; C Grappone; E Ranieri; G Pannarale; F P Schena
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.